ConductScience.org, home

Paper39223142

The disruption of NEAT1-miR-125b-5p-SLC1A5 cascade defines the oncogenicity and differential immune profile in head and neck squamous cell carcinoma.

Liu YC and 5 others. Cell Death Discov, 2024. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. The disruption of NEAT1-miR-125b-5p-SLC1A5 cascade defines the oncogenicity and differential immune profile in head and neck squamous cell carcinoma. Papers, record 39223142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39223142

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The disruption of NEAT1-miR-125b-5p-SLC1A5 cascade defines the oncogenicity and differential immune profile in head and neck squamous cell carcinoma.
PubMed
Journal
Cell Death Discov
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
1.81, provisional
iCite
Revised in PubMed
2024-09-05
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu YCYing-Chieh
2Liu SYSo-Yu
3Lin YCYu-Cheng
4Liu CJChung-Ji
5Chang KWKuo-Wei
6Lin SCShu-Chunhttps://orcid.org/0000-0001-8295-696X

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130293904Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion.Eur Urol2019https://conductscience.org/library/papers/30293904PubMed
231866442A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells.Cell Metab2020https://conductscience.org/library/papers/31866442PubMed
315175006Glutamine availability up-regulates expression of the amino acid transporter protein ASCT2 in HepG2 cells and stimulates the ASCT2 promoter.Biochem J2004https://conductscience.org/library/papers/15175006PubMed
431819178ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.Br J Cancer2020https://conductscience.org/library/papers/31819178PubMed
531055111MicroRNA miR-31 targets SIRT3 to disrupt mitochondrial activity and increase oxidative stress in oral carcinoma.Cancer Lett2019https://conductscience.org/library/papers/31055111PubMed
636950604SLC1A5, unrelated to prognosis, was associated with CD8+ T-cell exclusion in the tumor microenvironment of squamous cell carcinoma.Heliyon2023https://conductscience.org/library/papers/36950604PubMed
738528565The upregulation of VGF enhances the progression of oral squamous carcinoma.Cancer Cell Int2024https://conductscience.org/library/papers/38528565PubMed
828629361Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.J Biomed Sci2017https://conductscience.org/library/papers/28629361PubMed
928762332Long Noncoding RNA NEAT1 Promotes Proliferation and Invasion via Targeting miR-181a-5p in Non-Small Cell Lung Cancer.Oncol Res2018https://conductscience.org/library/papers/28762332PubMed
1035419359SLC1A5 Prefers to Play as an Accomplice Rather Than an Opponent in Pancreatic Adenocarcinoma.Front Cell Dev Biol2022https://conductscience.org/library/papers/35419359PubMed
1134630709Long non-coding RNA NEAT1 promotes the malignancy of laryngeal squamous cell carcinoma by regulating the microRNA-204-5p/SEMA4B axis.Oncol Lett2021https://conductscience.org/library/papers/34630709PubMed
1229100325Effects of targeting SLC1A5 on inhibiting gastric cancer growth and tumor development in vitro and in vivo.Oncotarget2017https://conductscience.org/library/papers/29100325PubMed
1333320840Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer.J Clin Invest2021https://conductscience.org/library/papers/33320840PubMed
1425821004Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer.Int J Cancer2015https://conductscience.org/library/papers/25821004PubMed
1527133077miR-125b inhibits keratinocyte proliferation and promotes keratinocyte apoptosis in oral lichen planus by targeting MMP-2 expression through PI3K/Akt/mTOR pathway.Biomed Pharmacother2016https://conductscience.org/library/papers/27133077PubMed
1630071532SLC1A5 Silencing Inhibits Esophageal Cancer Growth via Cell Cycle Arrest and Apoptosis.Cell Physiol Biochem2018https://conductscience.org/library/papers/30071532PubMed
1730917872Effects of glutamine deprivation on oxidative stress and cell survival in breast cell lines.Biol Res2019https://conductscience.org/library/papers/30917872PubMed
1836778122Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy.Int J Biol Sci2023https://conductscience.org/library/papers/36778122PubMed
1936289544LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer.J Exp Clin Cancer Res2022https://conductscience.org/library/papers/36289544PubMed
2030850586LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway.Cell Death Dis2019https://conductscience.org/library/papers/30850586PubMed

See all 41 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42642776Unraveling the role of glutamine metabolism in cancer: from cell death mechanisms to tumor microenvironment modulation.Exp Hematol Oncol2026https://conductscience.org/library/papers/42642776PubMed
42064548Cisplatin resistance in oral squamous cell carcinoma: mechanisms, reversal strategies, and emerging technologies.Front Physiol2026https://conductscience.org/library/papers/42064548PubMed
42005455Significance of SLC1A5 expression in head and neck squamous cell carcinoma: A bioinformatics and in-vitro analysis.J Oral Biol Craniofac Res2026https://conductscience.org/library/papers/42005455PubMed
41744616The Oncogenic Role of Long Non-Coding RNA NEAT1 in Head and Neck Squamous Cell Carcinoma: From Molecular Mechanisms to Clinical Implications.Biology (Basel)2026https://conductscience.org/library/papers/41744616PubMed
41606955Glutamine transporter SLC1A5 inhibits autophagy-mediated CD276 degradation to promote esophageal cancer progression.Cancer Biol Ther2026https://conductscience.org/library/papers/41606955PubMed
41585138The roles of CD24-Sec14 like lipid binding 2 (SEC14L2) axis in the neoplastic progression of oral squamous cell carcinomas.J Dent Sci2026https://conductscience.org/library/papers/41585138PubMed
41585137Apoptosis-inducing factor mitochondria-associated 2 (AIFM2) promotes tumor progression and predicts poor prognosis in oral squamous cell carcinoma.J Dent Sci2026https://conductscience.org/library/papers/41585137PubMed
41326881Crosstalk between miRNAs and oxidative stress: implications for cancer pathogenesis and therapy.Funct Integr Genomics2025https://conductscience.org/library/papers/41326881PubMed
41326356Immune cells dying from ferroptosis: mechanisms and therapeutic opportunities.Cell Death Dis2025https://conductscience.org/library/papers/41326356PubMed
40444100Immune-metabolic crosstalk in HNSCC: mechanisms and therapeutic opportunities.Front Oncol2025https://conductscience.org/library/papers/40444100PubMed
40095205Research progress on ferroptosis in head and neck squamous cell carcinoma.J Mol Histol2025https://conductscience.org/library/papers/40095205PubMed
39766175Saliva in Balancing Oral and Systemic Health, Oral Cancer, and Beyond: A Narrative Review.Cancers (Basel)2024https://conductscience.org/library/papers/39766175PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
MAP1LC3B81631PubTator's text mininghttps://conductscience.org/library/genes/81631NCBI Gene
NEAT1283131PubTator's text mininghttps://conductscience.org/library/genes/283131NCBI Gene
SLC1A56510PubTator's text mininghttps://conductscience.org/library/genes/6510NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39223142

GET https://conductscience.org/api/papers/v1/39223142/references?page=2